Tam LS, Gu J, Yu D. Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol. 2010;6:399–405.
PubMed
Google Scholar
Maksymowych WP. Disease modification in ankylosing spondylitis. Nat Rev Rheumatol. 2010;6:75–81.
PubMed
Google Scholar
Fallahi S, Mahmoudi M, Nicknam MH, et al. Effect of HLA-B*27 and its subtypes on clinical manifestations and severity of ankylosing spondylitis in Iranian patients. Iran J Allergy Asthma Immunol. 2013;12:321–30.
PubMed
Google Scholar
Karami J, Mahmoudi M, Amirzargar A, et al. Promoter hypermethylation of BCL11B gene correlates with downregulation of gene transcription in ankylosing spondylitis patients. Genes Immun. 2017;18:170–5.
CAS
PubMed
Google Scholar
Aslani S, Mahmoudi M, Garshasbi M, et al. Evaluation of DNMT1 gene expression profile and methylation of its promoter region in patients with ankylosing spondylitis. Clin Rheumatol. 2016;35:2723–31.
PubMed
Google Scholar
Vanaki N, Aslani S, Jamshidi A, et al. Role of innate immune system in the pathogenesis of ankylosing spondylitis. Biomed Pharmacother. 2018;105:130–43.
CAS
PubMed
Google Scholar
Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390:73–84.
PubMed
Google Scholar
Dashti N, Mahmoudi M, Aslani S, et al. HLA-B*27 subtypes and their implications in the pathogenesis of ankylosing spondylitis. Gene. 2018;670:15–21.
CAS
PubMed
Google Scholar
Rezaei R, Mostafaei S, Aslani S, et al. Association study between killer immunoglobulin-like receptor polymorphisms and ankylosing spondylitis disease: an updated meta-analysis. Int J Rheum Dis. 2018;21:1746–55.
CAS
PubMed
Google Scholar
Almasi S, Aslani S, Poormoghim H, et al. Gene expression profiling of toll-like receptor 4 and 5 in peripheral blood mononuclear cells in rheumatic disorders: Ankylosing spondylitis and rheumatoid arthritis. Iran J Allergy Asthma Immunol. 2016;15:87–92.
PubMed
Google Scholar
Ranganathan V, Gracey E, Brown MA, et al. Pathogenesis of ankylosing spondylitis — recent advances and future directions. Nat Rev Rheumatol. 2017;13:359.
CAS
PubMed
Google Scholar
Beringer A, Noack M, Miossec P. IL-17 in chronic inflammation: from discovery to targeting. Trends Mol Med. 2016;22:230–41.
CAS
PubMed
Google Scholar
Jiang YX, Li PA, Yang SW, et al. Increased chemokine receptor IL-17RA expression is associated with poor survival in gastric cancer patients. Int J Clin Exp Pathol. 2015;8:7002–8.
CAS
PubMed
PubMed Central
Google Scholar
Shen F, Gaffen SL. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine. 2008;41:92–104.
CAS
PubMed
PubMed Central
Google Scholar
Gaffen SL, Kramer JM, Yu JJ, et al. The IL-17 cytokine family. Vitam Horm. 2006;74:255–82.
CAS
PubMed
Google Scholar
Chang SH, Dong C. Signaling of Interleukin-17 family cytokines in immunity and inflammation. Cell Signal. 2011;23:1069–75.
CAS
PubMed
Google Scholar
Rezaiemanesh A, Abdolmaleki M, Abdolmohammadi K, et al. Immune cells involved in the pathogenesis of ankylosing spondylitis. Biomed Pharmacother. 2018;100:198–204.
CAS
PubMed
Google Scholar
Gu C, Wu L, Li X. IL-17 family: cytokines, receptors and signaling. Cytokine. 2013;64:477–85.
CAS
PubMed
Google Scholar
Bidad K, Salehi E, Jamshidi A, et al. Effect of all-transretinoic acid on Th17 and T regulatory cell subsets in patients with ankylosing spondylitis. J Rheumatol. 2013;40:476–83.
CAS
PubMed
Google Scholar
Mei Y, Pan F, Gao J, et al. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheumatol. 2011;30:269–73.
PubMed
Google Scholar
Jandus C, Bioley G, Rivals JP, et al. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum. 2008;58:2307–17.
PubMed
Google Scholar
Gaffen SL, Jain R, Garg AV, et al. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014;14:585–600.
CAS
PubMed
PubMed Central
Google Scholar
Goepfert A, Lehmann S, Wirth E, et al. The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties. Sci Rep. 2017;7:8906.
PubMed
PubMed Central
Google Scholar
Song X, Qian Y. IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases. Cell Signal. 2013;25:2335–47.
CAS
PubMed
Google Scholar
Ishigame H. Differential roles of interleukin-17A and -F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity. 2009;30:108–19.
CAS
PubMed
Google Scholar
Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol. 2009;9:556–67.
CAS
PubMed
PubMed Central
Google Scholar
Kehlen A, Thiele K, Riemann D, et al. Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis. Clin Exp Immunol. 2002;127:539–46.
CAS
PubMed
PubMed Central
Google Scholar
Abdolmohammadi K, Pakdel FD, Aghaei H, et al. Ankylosing spondylitis and mesenchymal stromal/stem cell therapy: a new therapeutic approach. Biomed Pharmacother. 2019;109:1196–205.
CAS
PubMed
Google Scholar
Soleimanifar N, Amirzargar AA, Mahmoudi M, et al. Study of programmed cell death 1 (PDCD1) gene polymorphims in Iranian patients with ankylosing spondylitis. Inflammation. 2011;34:707–12.
PubMed
Google Scholar
Daryabor G, Mahmoudi M, Jamshidi A, et al. Determination of IL-23 receptor gene polymorphism in Iranian patients with ankylosing spondylitis. Eur Cytokine Netw. 2014;25:24–9.
PubMed
Google Scholar
Mahmoudi M, Jamshidi AR, Amirzargar AA, et al. Association between endoplasmic reticulum aminopeptidase-1 (ERAP-1) and susceptibility to ankylosing spondylitis in Iran. Iran J Allergy Asthma Immunol. 2012;11:294–300.
CAS
PubMed
Google Scholar
Momenzadeh P, Mahmoudi M, Beigy M, et al. Determination of IL1 R2, ANTXR2, CARD9, and SNAPC4 single nucleotide polymorphisms in Iranian patients with ankylosing spondylitis. Rheumatol Int. 2016;36:429–35.
CAS
PubMed
Google Scholar
Vidal-Castineira JR, Lopez-Vazquez A, Diaz-Pena R, et al. A single nucleotide polymorphism in the Il17ra promoter is associated with functional severity of Ankylosing spondylitis. PLoS One. 2016;11:e0158905.
PubMed
PubMed Central
Google Scholar
Usher CL, McCarroll SA. Complex and multi-allelic copy number variation in human disease. Brief Funct Genomics. 2015;14:329–38.
CAS
PubMed
PubMed Central
Google Scholar
Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444:444–54.
CAS
PubMed
PubMed Central
Google Scholar
Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu Rev Med. 2010;61:437–55.
CAS
PubMed
Google Scholar
Gamazon ER, Stranger BE. The impact of human copy number variation on gene expression. Briefings Funct Genomics. 2015;14:352–7.
CAS
Google Scholar
Bigagli E, De Filippo C, Castagnini C, et al. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up. Cell Oncol (Dordr). 2016;39:545–58.
CAS
Google Scholar
Grayson BL, Smith ME, Thomas JW, et al. Genome-wide analysis of copy number variation in type 1 diabetes. PLoS One. 2010;5:e15393.
PubMed
PubMed Central
Google Scholar
Jung SH, Yim SH, Hu HJ, et al. Genome-wide copy number variation analysis identifies deletion variants associated with ankylosing spondylitis. Arthritis Rheumatol. 2014;66:2103–12.
CAS
PubMed
Google Scholar
Zochling J. Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S47–58.
Google Scholar
Qian Y, Liu C, Hartupee J, et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol. 2007;8:247–56.
CAS
PubMed
Google Scholar
Sadik CD, Kim ND, Alekseeva E, et al. IL-17RA signaling amplifies antibody-induced arthritis. PLoS One. 2011;6:e26342.
CAS
PubMed
PubMed Central
Google Scholar
Olsson LM, Holmdahl R. Copy number variation in autoimmunity--importance hidden in complexity? Eur J Immunol. 2012;42:1969–76.
CAS
PubMed
Google Scholar
Shahba S, Jafari Shakib R, Jamshidi A, et al. Association study of copy number variation in BMP8A gene with the risk of ankylosing spondylitis in Iranian population. J Cell Biochem. 2018.
Myhre S, Lingjaerde OC, Hennessy BT, et al. Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins. Mol Oncol. 2013;7:704–18.
CAS
PubMed
PubMed Central
Google Scholar
Mahmoudi M, Aslani S, Nicknam MH, et al. New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications. Mod Rheumatol. 2017;27:198–209.
PubMed
Google Scholar
Veitia RA, Bottani S, Birchler JA. Gene dosage effects: nonlinearities, genetic interactions, and dosage compensation. Trends Genet. 2013;29:385–93.
CAS
PubMed
Google Scholar
Hollox EJ, Hoh BP. Human gene copy number variation and infectious disease. Hum Genet. 2014;133:1217–33.
CAS
PubMed
Google Scholar
Henrichsen CN, Chaignat E, Reymond A. Copy number variants, diseases and gene expression. Hum Mol Genet. 2009;18:R1–8.
CAS
PubMed
Google Scholar
Thomas GP, Duan R, Pettit AR, et al. Expression profiling in spondyloarthropathy synovial biopsies highlights changes in expression of inflammatory genes in conjunction with tissue remodelling genes. BMC Musculoskelet Disord. 2013;14:354.
PubMed
PubMed Central
Google Scholar
Wang X, Lin Z, Wei Q, et al. Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatol Int. 2009;29:1343–7.
CAS
PubMed
Google Scholar
Chen W-S, Chang Y-S, Lin K-C, et al. Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis. J Chinese Med Assoc. 2012;75:303–8.
CAS
Google Scholar
Raychaudhuri SP, Raychaudhuri SK, Genovese MC. IL-17 receptor and its functional significance in psoriatic arthritis. Mol Cell Biochem. 2012;359:419–29.
CAS
PubMed
Google Scholar
Koenders MI, Kolls JK, Oppers-Walgreen B, et al. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall–induced arthritis. Arthritis Rheumatism. 2005;52:3239–47.
CAS
PubMed
Google Scholar
Lee W, Reveille JD, Davis JC, et al. Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis. 2007;66:633–8.
PubMed
Google Scholar
Shahlaee A, Mahmoudi M, Nicknam MH, et al. Gender differences in Iranian patients with ankylosing spondylitis. Clin Rheumatol. 2015;34:285–93.
PubMed
Google Scholar
Gracey E, Yao Y, Green B, et al. Sexual dimorphism in the Th17 signature of Ankylosing spondylitis. Arthritis Rheumatol. 2016;68:679–89.
CAS
PubMed
Google Scholar